COMPASS+ for Perinatal Mental Health
(COMPASS+ Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new approach called COMPASS+ to improve mental health care for pregnant and postpartum individuals. It aims to determine if this approach can better manage depression symptoms and reduce suicidal thoughts compared to standard care. The trial will also assess the approach's effectiveness across different racial and ethnic groups. Pregnant individuals or those who recently had a baby and are receiving care at a participating site may qualify for this study. As an unphased trial, this study offers a unique opportunity to contribute to groundbreaking research that could enhance mental health care for diverse populations.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that the COMPASS+ model is safe for perinatal mental health care?
Research has shown that the COMPASS+ program is designed to help with depression during and after pregnancy. It provides mental health support, regular check-ins with health managers, and team meetings with a psychiatrist. Past participants found this type of care manageable. The program includes talking therapies and, if needed, medications tailored to each person.
No specific reports of major safety concerns have emerged with COMPASS+. The focus on support and monitoring helps catch any issues early. This careful approach ensures that treatments can be adjusted as needed, making the program safe for participants.12345Why are researchers excited about this trial?
Unlike the standard of care for perinatal mental health, which often involves general screenings and community referrals, COMPASS+ offers a more integrated approach. This program embeds mental health services directly into perinatal care, providing continuous support through a dedicated behavioral health care manager. Researchers are excited because COMPASS+ includes a patient registry and regular team meetings supervised by a perinatal psychiatrist, ensuring personalized and responsive care. This proactive and coordinated approach aims to address mental health issues more effectively during and after pregnancy, potentially improving outcomes for new mothers.
What evidence suggests that COMPASS+ is effective for perinatal mental health?
Research has shown that the COMPASS+ program, available to participants in this trial, can help treat depression during and after pregnancy. Studies indicate that the approach used in COMPASS+ improves depression and reduces disparities in healthcare access. This method combines mental health support with regular medical care, offering services like medication and therapy. The program aims to improve the well-being of women with depression through personalized treatment and regular check-ins. Early results suggest that these strategies can lead to better mental health outcomes for many women.35678
Are You a Good Fit for This Trial?
This trial is for individuals experiencing mental health challenges during the perinatal period, which includes pregnancy and the first year after giving birth. The study aims to include a diverse population to assess the effectiveness of COMPASS+ across different racial and ethnic groups.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Implementation
Implementation of COMPASS+ services, including mental health support and monitoring by a behavioral health care manager
Treatment
Participants receive mental health support services and monitoring by a behavioral health care manager, with PHQ9 scores collected every 4 weeks
Follow-up
Participants are monitored for depression symptom response and remission, and suicidal ideation using PHQ9 scores
What Are the Treatments Tested in This Trial?
Interventions
- COMPASS+
Find a Clinic Near You
Who Is Running the Clinical Trial?
Women and Infants Hospital of Rhode Island
Lead Sponsor
National Institute of Nursing Research (NINR)
Collaborator
Brown University
Collaborator